CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
8 research outputs found
Introduction: Expanding the horizons in unstable coronary artery disease
Author
Antman
Cohen
+11Â more
Cohen
Fragmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators
Fragmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators
Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group
Holdright
Klein
Leizorovicz A and the FRAX.I.S Study Group
The RISC group
The Thrombin Inhibition in Myocardial Ischemia (TRIM) Study Group
Théroux
Théroux
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Acute coronary care and beyond: The expanding role of low-molecular-weight heparin
Author
Antman
Bertrand
+9Â more
Cohen
Dunn
Fragmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators
Fragmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators
Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group
Kaul
Klein
The FRAX.I.S. Study Group
Xiao
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease
Author
Antman
Bertrand
+29Â more
Boden
Cairns
Cohen
Cohen
Eikelboom
FRagmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators
FRagmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators
FRagmin during Instability in Coronary artery disease (FRISC) study group
Granger
Gurfinkel
Hamm
Hirsh
Holdright
Kaul
Kereiakes
Klein
Lewis
Lindahl
Lindahl
Merlini
The FRAX.I.S. Study Group
The RISC Group
The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators
Thrombin Inhibition in Myocardial Ischaemia (TRIM) Study Group
Théroux
Théroux
Théroux
Wallentin
Wallentin
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Guidelines for the acute coronary syndromes
Author
A Oler
AGG Turpie
+26Â more
CURE Study Investigators
DJ Kereiakes
E Boersna
E Braunwald
EJ Topol
Elliot Rapaport
EM Antman
EM Antman
EM Antman
F Balsano
FRISC II Investigators
HD Lewis
J Moore
JA Cairns
JE Calvin
JJ Ferguson
JM Herbert
M Cohen
OASIS-2 Investigators
PC Gazes
RISC Group
RM Califf
Task Force of the European Society of Cardiology
The FRAX.I.S. Study Group
TIMI IIIb Investigators
WE Boden
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial
Author
Alexander
Anderson
+24Â more
Avezum
Blazing
Brieger
Cohen
de Lemos
G. Marcucci
Giugliano
Giugliano
Gore
H. D. White
J. Col
K. P. Alexander
K. W. Mahaffey
LaPointe
P. E. Aylward
Petersen
R. D. Lopes
R. M. Califf
S. Spinler
Singh
SYNERGY Trial Investigators
The Frax.I.S. Study Group
White
Zeymer
Publication venue
'Oxford University Press (OUP)'
Publication date
Field of study
No full text
Crossref
Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital
Author
A Bazinet
A Frydman
+29Â more
AD Michaels
AJ Camm
BL Anglemyer
BW Lin
C Macie
DR Jacobs Jr
G Montalescot
Geng Xu
Haibin Dai
Hongwen Cai
HS Al-Sallami
Huimin Xu
J Hirsh
J Hirsh
JP Collet
JP Singer
KA Fox
KP Alexander
M Cohen
MA Font
ME Bauman
P Schmid
P Schmid
S Schulman
TE Warkentin
The FRAX.I.S. Study Group
W Klein
Xiaofeng Yan
Zhongshu Qian
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Unfractionated Heparin and Low Molecular Weight Heparin in Ischemic Heart Disease
Author
Anand
Antman
+72Â more
Antman
Antman
Antman
Antman
Antman
Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators
Becker
Becker
Bhatt
Blazing
Braunwald
Braunwald
Cheng
Cohen
Cohen
Cohen
Cohen
Cohen
Cohen
Cohen
Dumaine
Fareed
Fareed
Ferguson
Ferguson
Flaker
Fragmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators
Fragmin during Instability in Coronary Artery Disease (FRISC) study group
Frostfeldt
Gibson
Glick
Goodman
Goodman
Granger
Gurfinkel
Hainer
Hirsh
Hochman
Hoppensteadt
Hulot
Katsouras
Kereiakes
Kereiakes
Kereiakes
Klein
Kontny
Martin
Martin
Michalis
Montalescot
Montalescot
Montalescot
Montalescot
Montalescot
Mukherjee
Murphy
Oler
Petersen
Ross
Sanderink
Sanderink
Simoons
Simoons
Spinler
The FRAX.I.S. Study Group
Théroux
Théroux
Wallentin
White
Wiviott
Yusuf
Zidar
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Medical Therapy in Patients Managed in a Chest Pain Observation Unit
Author
AM Telford
CA Henrikson
+36Â more
Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
D Holdright
DB Diercks
DO Williams
EM Antman
EP Gurfinkel
F Werf Van de
GG Neri Serneri
GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction.
GW Stone
HD Lewis Jr
IM Barbash
ISIS-4: a randomised factorial trial assessing early oral captopril oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction.
JA Cairns
JJ Ferguson
JL Anderson
JL Petersen
K Ellis
KP Alexander
L Erhardt
L Hansson
Low-molecular-weight heparin during instability in coronary artery disease Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
M Cohen
M Cohen
MA Blazing
N Freemantle
P Theroux
R Roberts
S Yusuf
S Yusuf
S Yusuf
SG Goodman
Steering Committee of the Physicians' Health Study Research Group.
The RISC Group.
W Klein
ZM Chen
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref